Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation

Name: Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Uploaded: 2024-10-02T14:54:46+00:00
Duration: 1 min 20 s
Channel: Benzinga
Description: Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch

Benzinga

Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch

Category

Comments

Recommended